đ° Alligator Bioscience News
Page 5 - Alligator Bioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alligator Bioscience. Real-time updates on events, politics, business and more.
December 15, 2021
/PRNewswire/ -- Alligator Bioscience AB ("Alligator") and Aptevo Therapeutics ("Aptevo") (NASDAQ: APVO) today announced publication of an article in the...
December 8, 2021
Amphera B.V., a late-stage biotechnology company developing MesoPher cell therapy to treat cancer, announces significant progress in its two clinical programs in pancreatic cancer as well as the full
December 8, 2021
Press release content from Business Wire. The AP news staff was not involved in its creation.
October 21, 2021
/PRNewswire/ -- First Patient Dosed in Optimize-1 Phase II "We continued to make great strides in the third quarter of 2021. The first patient was dosed in...
October 20, 2021
ORION CORPORATION INTERIM REPORT 1-9/2021 20 OCTOBER 2021 at 12:00 noon EEST Orion Group Interim Report 1-9/2021 This is a summary of Orion's Interim Report 1-9/2021. The
October 7, 2021
/PRNewswire/ -- The shareholders of Alligator Bioscience AB, Reg. No. 556597-8201 ("Alligator"), are invited to the extraordinary general meeting to be held on...
August 18, 2021
/PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) announced today that the company has entered into a research collaboration and license agreement...
June 7, 2021
/PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announces that the scientific journal Expert Opinion on Biological Therapy has published...
June 1, 2021
/PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX), today announces that the annual general meeting was held in the company this day. In light of...
May 4, 2021
2021-05-21 08:40 Xintela meddelar idag att bolaget har erhÄllit tillstÄnd frÄn LÀkemedelsverket att producera cellterapiprodukter, sÄ kallade avancerade terapilÀkemedel (ATMPs), i den egna GMP-anlÀggningen. 2021-05-21 08:40 Xintela announces today that the company has received permission from the Medical Products Agency to produce cell therapy products, so-called advanced therapy drugs (ATMPs), in its own GMP facility. 2021-05-20 11:40 Xintela tillkÀnnager idag att bolaget ska utveckla ...